allicin has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ROCCHIETTA, S | 1 |
| CARRUTHERS, C; DIPAOLO, JA | 1 |
| Lander, HM; Mirelman, D; Miron, T; Novogrodsky, A; Patya, M; Rabinkov, A; Vanichkin, A; Wilchek, M; Zahalka, MA | 1 |
3 other study(ies) available for allicin and Experimental Neoplasms
| Article | Year |
|---|---|
[Derivatives of allicin, the active principal of garlic, and their inhibitory action on the growth of tumors].
Topics: Allium; Animals; Disulfides; Garlic; Neoplasms; Neoplasms, Experimental; Sulfinic Acids | 1958 |
The effect of allicin from garlic on tumor growth.
Topics: Animals; Disulfides; Garlic; Neoplasms; Neoplasms, Experimental; Sulfinic Acids | 1960 |
Allicin stimulates lymphocytes and elicits an antitumor effect: a possible role of p21ras.
Topics: Amino Acid Substitution; Animals; Anti-Infective Agents; Cytotoxicity, Immunologic; Disulfides; Enzyme Activation; Humans; Jurkat Cells; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oncogene Protein p21(ras); Oxidation-Reduction; Signal Transduction; Sulfinic Acids; T-Lymphocytes | 2004 |